PHC Group appoints Shoji Miyazaki as CEO and announces Board Member Koichiro Sato as upcoming COO

– JAPAN, Tokyo –  PHC Holdings Corporation (TYO: 6523) today announced the appointment of Shoji Miyazaki as CEO, succeeding John Marotta, who has stepped down as CEO and from the Board of Directors effective April 28, 2022.

Shoji Miyazaki remains a Representative Director on the Board of Directors.

About Shoji Miyazaki

Shoji Miyazaki was previously PHC Group’s COO and former President of PHC Corporation and brings more than 30 years of experience at PHC Group and Panasonic. He joined Matsushita Kotobuki Electronics Co., Ltd. a predecessor of PHC Corporation in 1990, upon graduation. In 2001 he moved to Panasonic’s healthcare medical business unit, focusing on medical diagnostics, where he continued in numerous roles before being appointed EVP and COO of PHC Holdings Corporation in 2020. At the same time, he also held Board positions at PHC Corporation and LSI Medience Corporation.

“I look forward to focusing on efficiency and integration, building on the work our team has delivered integrating our teams and portfolio since the acquisitions of Epredia and LSI Medience in 2019. Delivering value for patients, clinicians, business partners, and shareholders remains PHC Group’s top priority,” said Shoji Miyazaki.

In addition, effective July 1, 2022, Board Member Koichiro Sato will join PHC Group as COO. On the same date, subject to the approval of the proposal for election of directors at the General Meeting of Shareholders, he will become a Representative Director. His main responsibility will be overseeing company operations outside of Japan, where half of PHC Group’s business and employees are located, including Ascensia, Epredia, and PHCbi NA and EU. Sato joins PHC Group from his current role as CEO in the Hong Kong Branch of MBK Healthcare Management Pte. Ltd. and he brings nearly 25 years of experience to PHC Group from his international career within Mitsui & Co. related companies. He entered the healthcare field in 2016 as a general manager in the Mitsui healthcare business division.

“We are pleased to welcome Shoji Miyazaki as PHC Group’s new CEO. He has a strong track record of leading global teams across diagnostics, life sciences, and diabetes, and is particularly well suited to driving the next leg of innovation from PHC Group. We continue to be committed to creating healthcare solutions that improve lives and strengthen our communities,” said Kyoko Deguchi, External Director.

About PHC Holdings Corporation (PHC Group)

PHC Holdings Corporation is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries include PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia, and LSI Medience Corporation. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, life sciences, and diagnostics. PHC Group’s consolidated net sales in FY2020 were JPY 306 billion with global distribution of products and services in more than 125 countries.

For more information: https://www.phchd.com/global

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.